Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Dec 16, 2022

Keywords

ClinConnect Summary

This clinical trial, called "Remote Resistance Exercise Powering Survivors," is looking at how a special exercise program delivered online can help people undergoing chemotherapy for advanced upper gastrointestinal (GI) cancer. The goal is to see if this remote exercise training can improve strength and overall well-being for those fighting this type of cancer.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of advanced upper GI cancer (stages III or IV). They should also be able to read and speak English and be planning to return to Moffitt Cancer Center for further treatment. While the trial is open to anyone meeting these criteria, it excludes those who already engage in regular resistance training, have certain health issues that could affect their ability to exercise safely, or experience significant pain. Participants can expect to take part in guided exercise sessions online, which will be tailored to their needs and abilities during their treatment journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Biopsy-proven upper GI cancer, stage III-IV
• • ECOG performance status 0-1
• • Treatment plan of chemotherapy with planned return to Moffitt Cancer Center for restaging
• • Able to read and speak English fluently
• • Capable of providing informed consent
• Exclusion Criteria:
• • Regular engagement in RT (2x/week targeting all major muscle groups)
• • Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q) and Patient-Reported Measurement Information System (PROMIS) screening questions
• • Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV).
• • Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT
• • Numeric pain rating scale of ≥ 7 out of 10
• • Myopathic or rheumatologic disease that impacts physical function